Linjardy Mxr (10/5/1000mg) 14 Tablets
Empagliflozin, Linagliptin, and Metformin XR for type 2 diabetes.
Linjardy Mxr 10/5/1000mg is a triple combination of empagliflozin 10mg (SGLT2 inhibitor), linagliptin 5mg (DPP-4 inhibitor), and metformin 1000mg (extended-release). Used for type 2 diabetes when diet and exercise are insufficient. Take once daily in the morning with a meal. Swallow whole; do not crush or chew. Pack of 14 tablets.
Purpose
Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise.
Ingredients
Empagliflozin 10mg, Linagliptin 5mg, and Metformin hydrochloride 1000mg (extended-release) per tablet.
Warnings
Contraindicated in severe renal impairment (eGFR <45), diabetic ketoacidosis. Risk of lactic acidosis. Not for type 1 diabetes.
Side Effects
Genital and urinary tract infections, nausea, diarrhea. Rare: lactic acidosis (metformin), ketoacidosis.
Storage Instructions
Store below 25C in a dry place. Keep in original pack to protect from moisture.
| Brand | CCL |
| Status | Active |
Related Products
